Literature DB >> 20887127

Growth hormone-secreting adenomas: pathology and cell biology.

M Beatriz S Lopes1.   

Abstract

The majority of patients with acromegaly harbor a functioning growth hormone (GH) pituitary adenoma. Growth hormone–secreting adenomas correspond to about 20% of all pituitary adenomas. From the histopathological point of view, a variety of adenomas may present with clinical signs and symptoms of GH hypersecretion including pure GH cell adenomas (densely and sparsely granulated GH adenomas), mixed GH and prolactin cell adenomas, and monomorphous adenomas with primitive cells able to secrete GH and prolactin including the acidophilic stem cell adenoma and the mammosomatotroph cell adenoma. In this article, the author reviews the main pathological features of the GH-secreting adenomas and some of the molecular genetics mechanisms involved in their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887127     DOI: 10.3171/2010.7.FOCUS10169

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  27 in total

1.  Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells.

Authors:  Aurora Aiello; Maria Francesca Cassarino; Simona Nanni; Antonella Sesta; Francesco Ferraú; Claudio Grassi; Marco Losa; Francesco Trimarchi; Alfredo Pontecorvi; Salvatore Cannavò; Francesca Pecori Giraldi; Antonella Farsetti
Journal:  Endocrine       Date:  2017-04-26       Impact factor: 3.633

Review 2.  Clinical implications of growth hormone-secreting tumor subtypes.

Authors:  Katja Kiseljak-Vassiliades; Shibana Shafi; Janice M Kerr; Tzu L Phang; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Endocrine       Date:  2012-03-21       Impact factor: 3.633

Review 3.  Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.

Authors:  Luis V Syro; Fabio Rotondo; Carlos A Serna; Leon D Ortiz; Kalman Kovacs
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.

Authors:  Yuichi Nagata; Naoko Inoshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Hiroshi Nishioka; Takeo Iwata; Katsuhiko Yoshimoto; Shozo Yamada
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

Review 5.  Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas.

Authors:  Ricardo J Komotar; Robert M Starke; Daniel M S Raper; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 6.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

Review 7.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

8.  IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomas.

Authors:  Amit Akirov; Yona Greenman; Benjamin Glaser; Irena S'chigol; Yossi Mansiterski; Yoav Eizenberg; Ilana Shraga-Slutzky; Ilan Shimon
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

9.  Risperidone-induced acromegaly: a case report.

Authors:  Ayşe Koroglu; Cicek Hocaoglu
Journal:  Ther Adv Psychopharmacol       Date:  2012-04

10.  Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly.

Authors:  Hai Sun; Jessica Brzana; Chris G Yedinak; Sakir H Gultekin; Johnny B Delashaw; Maria Fleseriu
Journal:  J Neurol Surg B Skull Base       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.